Seagen Liabilities 2024

Seagen Aktienanalyse

What does Seagen do?

Seagen Inc is a pharmaceutical and biotech company specialized in the development of drugs for cancer treatment and supporting the health of patients with chronic diseases. The company was founded in 1997 and has its headquarters in Bothell, Washington. Seagen Inc's history began when the founders, Clay Siegall and H. Perry Fell, decided to establish a company focused on developing innovative technologies and biological solutions for fighting cancer. The company started with a small workforce and a focus on the development of antibodies against cancer cells. Over the years, Seagen has become a major player in the industry and has launched several successful drugs worldwide. Seagen Inc specializes in the development of cancer medications, including antibodies against cancer cells. The company strives to improve the effectiveness of cancer treatments and reduce the number of side effects. Its flagship products are Adcetris and Padcev, both used for the treatment of specific types of cancer. Adcetris (Brentuximab Vedotin) is an antibody-drug conjugate and the first of its kind approved worldwide for use against Hodgkin lymphomas and systemic anaplastic large cell lymphoma. It contains a special chemical that is bound to an antibody to directly attack cancer cells. Adcetris has proven to be very effective against lymphomas and is available on prescription in many countries. Padcev (Enfortumab Vedotin-ejfv) is another antibody-drug conjugate used for the treatment of bladder cancer. The drug has shown effectiveness in clinical studies and has been approved by the FDA to help patients who have no other treatment options. Padcev is being developed and marketed by Seagen in collaboration with Astellas Pharma. In addition to developing cancer medications, Seagen Inc is also involved in the research and development of technologies for autoimmune disease therapy. The company has developed a technology platform that has proven to be highly effective in the development of antibody-based therapies. This platform is used both internally and in partnerships with other pharmaceutical companies. Seagen Inc also leverages partnerships to expand its business globally and advance the development of new therapies. The company has entered into a strategic partnership with Takeda Pharmaceutical to support the development and commercialization of Adcetris. Additionally, Seagen Inc collaborates with various universities and research institutions to develop new technologies and treatment options. Overall, Seagen Inc has experienced strong growth in recent years and has become a major player in the biotech and pharmaceutical industry. The company remains committed to its mission of developing innovative technologies and solutions for fighting cancer and other chronic diseases. Seagen ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Liabilities Details

Assessing Seagen's Liabilities

Seagen's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Seagen's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Seagen's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Seagen's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Seagen’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Seagen stock

What is the level of liabilities of Seagen this year?

Seagen has a debt balance of 870.7 M USD this year.

What were the liabilities of Seagen compared to the previous year?

The liabilities of Seagen have increased by 33.03% increased compared to the previous year.

What are the consequences of high debt for investors of Seagen?

High liabilities can pose a risk for investors of Seagen, as they can weaken the company's financial position and impair its ability to meet its obligations.

What consequences do low liabilities have for investors in Seagen?

Low liabilities mean that Seagen has a strong financial position and is able to meet its obligations without overburdening its finances.

How does an increase in liabilities of Seagen affect the company?

An increase in liabilities of Seagen can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.

How does a reduction in the liabilities of Seagen affect the company?

A decrease in the liabilities of Seagen can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.

What are some factors that influence the liabilities of Seagen?

Some factors that can influence the liabilities of Seagen include investments, acquisitions, operating costs, and sales development.

Why is the level of liabilities of Seagen so important for investors?

The liabilities of Seagen are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.

What strategic measures can Seagen take to modify the liabilities?

To change its liabilities, Seagen can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.

How much dividend does Seagen pay?

Over the past 12 months, Seagen paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Seagen is expected to pay a dividend of 0 USD.

What is the dividend yield of Seagen?

The current dividend yield of Seagen is .

When does Seagen pay dividends?

Seagen pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Seagen?

Seagen paid dividends every year for the past 0 years.

What is the dividend of Seagen?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Seagen located?

Seagen is assigned to the 'Health' sector.

Wann musste ich die Aktien von Seagen kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Seagen from 8/27/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 8/27/2024.

When did Seagen pay the last dividend?

The last dividend was paid out on 8/27/2024.

What was the dividend of Seagen in the year 2023?

In the year 2023, Seagen distributed 0 USD as dividends.

In which currency does Seagen pay out the dividend?

The dividends of Seagen are distributed in USD.